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Smoking tobacco-based products harms nearly every organ in the body and has been linked causally to a diminished health status 
in general. Specifically, smoking is linked to several 
non-communicable diseases (NCDs) which have 
recently advanced their ranking among the most 
frequently reported causes of death in the Arab world.1 
Tobacco-related cancers include lung cancer, head 
and neck cancers, bladder cancers and leukaemia.2 
New evidence has emerged suggesting that colorectal 
and liver cancers are also caused by smoking.2 In 
addition, smoking is a common risk factor for other 
NCDs, namely cardiovascular diseases and respiratory 
illnesses and is an independent risk factor for diabetes 
mellitus; in fact, smoking raises an individual’s risk 
of developing diabetes by 30–40% compared to non-
smokers.2 
The annual death toll caused by tobacco use, which 
stood in 2008 at five million, is expected to rise to 
eight million by 2030, with individuals from low- and 
middle-income countries making up approximately 
80% of these deaths.3 Tobacco smoking, including 
second-hand smoke inhalation, ranked third in terms 
of the global burden of disease in 1990; today, it is 
now ranked second within an array of risk factors.4 In 
North Africa and the Middle East, tobacco smoking, 
including second-hand smoke inhalation, ranked third 
in 2010 only after high blood pressure and a high 
body mass index (BMI), based on the attributable 
burden of disease.4 Results from the World Health 
Cancer Control Office, King Hussein Cancer Center, Amman, Jordan
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النهوض باخلدمات العالجية إلدمان التبغ يف منطقة شرق املتوسط
تعاون دويل للتدريب وبناء القدرات
فرا�س الهواري و ر�شا بدر
abstract: Tobacco use negatively affects health and is a major risk factor for non-communicable diseases 
(NCDs). Today, tobacco use ranks third among risk factors in North Africa and the Middle East in terms of 
disease burden. Despite the established need for these services, tobacco dependence treatment (TDT) services 
are still inadequate in the Eastern Mediterranean region (EMR). Among the main challenges hindering their 
expansion is the current lack of training opportunities. The provision of training and capacity-building—a key 
enabler of TDT—offers an excellent catalyst to launch TDT services in the region. This review discusses the 
need for TDT training in the EMR and describes a model for providing regional evidence-based training in line 
with international standards. The King Hussein Cancer Center in Amman, Jordan, is the regional host for Global 
Bridges, a worldwide TDT initiative. Using this model, they have trained 1,500 professionals and advocates from 
the EMR over the past three years.
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لعوامل  الثالثة  املرتبة  التبغ  يحتل  ال�شارية.  غري  للأمرا�س  كبري  خطر  عامل  و  ال�شحة  على  �شلبية  تاأثريات  ذا  التبغ  يعترب  امللخ�ص: 
الخطرمن ناحية عبء املر�س يف �شمال اأفريقا و ال�رشق الأو�شط. بالرغم من احلاجة املعتمدة لهذه اخلدمات، تعترب خدمات علج اإدمان 
التبغ يف الوقت احلايل غري كافية يف منطقة �رشق املتو�شط. ويعترب النق�س احلايل يف فر�س التدريب من اأهم التحديات التي تعيق تو�شع 
هذه اخلدمات. اال�شتعداد امل�شبق للتدريب وبناء القدرات هام املفتاح لتمكني علج اإدمان التبغ حيث تعطي حافزا ممتازا النطلق اخلدمات 
املتو�شط  �رشق  منطقة  يف  التبغ  اإدمان  علج  يف  للتدريب  احلاجة  االستعرايض  املقال  هذا  يناق�س  املنطقة.  يف  التبغ  لإدمان  العلجية 
هو م�شيف  الأردن،  بعمان،  لل�رشطان  مركزاحل�شني  الدولية.  للمعايري  موازي  و  الأدلة  على  قائم  اإقليمي  تدريب  اعطاء  وت�شف منوذج 
اإقليمي ملبادرة اجل�شور العاملية، كاملبادرة العاملية لعلج اإدمان التبغ. باإ�شتخدام هذا النموذج، مت تدريب 1500 من املهنيني وموؤيدي 
املبادئ من منطقة �رشق املتو�شط خلل الثلث �شنوات املا�شية.
مفتاح الكلمات: الأمرا�س غري ال�شارية؛ التدريب؛ اإدمان التبغ؛ الإقلع عن التدخني؛ بناء القدرات؛ �رشق املتو�شط.
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World Bank estimated that 200 million deaths could 
be prevented by 2050 if adult tobacco consumption 
were to be halved by 2020.9 In comparison, halving the 
number of young people who take up smoking would 
have a negligible effect on short-term mortality rates.9
The inclusion of smoking cessation advice in 
primary healthcare settings has proven to be a low-cost 
strategy since the only major investment required is in 
training providers and availing informational materials 
to tobacco users.3 However, pharmacotherapy, while 
more expensive than offering cessation advice, has 
been shown to double or triple quit rates.3 In general, 
TDT interventions are extremely cost-effective 
when compared to the treatment of other chronic 
diseases. For example, compared to treatments for 
hypertension, TDT saves three times as many lives and 
takes on average only around two hours of a specialist’s 
time, which is much quicker than the time required 
to treat a case of hypertension.10 In general, the cost-
effectiveness of TDT exceeds that of other commonly 
provided clinical preventative services, including Pap 
tests, mammographies and screening for colon cancer, 
as well as treatment for high serum cholesterol levels 
and mild to moderate hypertension.11
Different countries have adopted different 
systems for offering TDT, building on variables such 
as income level, as was observed in a case series on 
TDT implementation in Brazil, England, India, South 
Africa and Uruguay.12 Not all of the studied countries 
had national policies mandating that this treatment be 
offered, and furthermore, while some of the countries’ 
TDT policies relied on offering broadly available brief 
advice, others were dependent on specialist support 
which was often limited in availability. In addition, the 
extent of medication coverage and reimbursement of 
provider time varied from one country to another.12 
However, training and skill-building are integral 
to various models of TDT provision. For example, 
England, a high-income country, offers TDT as part of 
their National Health Service (NHS) plan. Both widely 
available brief advice and more intensive specialist 
support are offered to smokers, with the majority of 
the costs covered by the NHS. In this model, significant 
emphasis is placed on the training and skills of service 
providers and England has accordingly established 
a national centre to address training, certification 
and performance evaluation for TDT providers.12 
In Uruguay, an upper-middle-income country of 3.5 
million, 100 TDT programmes were established by 
2010. These programmes offer training to HCPs and 
provide free TDT medication to smokers. Moreover, 
Uruguayan law mandates that public and private 
service providers record the smoking status of all 
patients in their medical notes, incorporate a diagnosis 
Organization (WHO) Report on the Global Tobacco 
Epidemic in 2008 indicate that the age-standardised 
prevalence of tobacco smoking among men in the 
Eastern Mediterranean region (EMR) ranged from 
63% in Jordan and 51% in Tunisia to 25% in Oman.3 
In 2012, the estimated age-standardised prevalence of 
daily smoking among men in the EMR ranged from 
43% in Jordan and 45% in Tunisia to 13% in Oman.5
For an individual, quitting smoking brings about 
immediate health benefits, including the normalisation 
of heart rate and blood pressure and a decrease in 
coughing and the production of phlegm.6 In the long 
term, quitting tobacco generally reduces the risk of 
disease and premature death by 90% for those who 
quit before the age of 30 and by 50% for those who 
quit before the age of 50.6 Five years after quitting, 
the risk of stroke falls to that of a non-smoker and 
the risk of head, neck and bladder cancers is reduced 
by half.7 One of the six policies recommended by the 
WHO to counter the tobacco epidemic is a country-
level initiative in offering help to smokers in quitting 
tobacco use; these measures are intended to assist in 
reducing the demand for tobacco.3 However, despite 
this policy and the documented short- and long-term 
benefits of quitting smoking, tobacco dependence 
treatment (TDT) services continue to be scarce and 
inconsistent across the EMR. Many factors contribute 
to this shortage of TDT services, including the lack of 
training opportunities for healthcare providers (HCPs) 
in the basic skills needed to deliver these services. 
This review justifies the urgent need for establishing 
TDT services across the EMR and describes a model 
of international collaboration that addresses one of 
the most important limitations for establishing these 
services—the training of HCPs in delivering effective 
and relevant TDT to interested smokers.
Tobacco Dependence 
Treatment
TDT is an integral component of any comprehensive 
tobacco control effort. In Article 14 of their Framework 
Convention on Tobacco Control (FCTC), the WHO 
mandates that parties should design and implement 
effective programmes to promote the cessation of 
tobacco use and provide adequate treatment for 
tobacco dependence.8 They furthermore recommend 
the inclusion of cessation advice in primary healthcare 
services, establishing accessible and free ‘quitlines’ 
and making low-cost pharmacotherapy available to 
interested smokers.3,8 Likewise, in a report issued in 
1999, the World Bank urged governments seeking 
health and economic gains to encourage smokers 
to quit.9 Building on previously published data, the 
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of tobacco dependence and offer relevant treatment 
through primary care programmes.12 National 
guidelines are in place and efforts are underway to 
ensure that the national treatment programmes have 
complete population coverage.12 Brazil and India, 
two lower-middle-income countries, have focused 
on establishing a limited number of specialised 
treatment units.12 These services, while not necessarily 
wide-reaching, act as training hubs for HCPs. 
Although only Brazil currently has a national TDT 
policy, both countries have developed and adopted 
national TDT guidelines.12,13 Medication is available 
through treatment units in both countries but is only 
reimbursed in Brazil.12 
The situation in the EMR is similar to that in 
other parts of the world; while a significant number of 
smokers have shown interest in quitting, the availability 
of TDT services continues to be limited and grows 
only marginally from year to year.3,14‒16 Accordingly, 
TDT services are not consistently available across the 
EMR and are not yet integrated within the healthcare 
system. While some countries, including Kuwait, the 
United Arab Emirates (UAE) and Iran, offer a ‘quitline’ 
and cover costs for cessation services and nicotine 
replacement therapies (NRTs), most EMR countries 
offer partial to no coverage for smokers attempting 
to quit.14 Correspondingly, the data on screening for 
tobacco use demonstrate that there is insufficient 
screening and advice for smokers. For example, data 
from 2009 indicated that only 22% of smokers in 
Egypt had visited an HCP in the previous 12 months.17 
Among smokers, only 74% were screened for smoking 
and, of those screened, only 67% were advised to quit 
smoking.17 In Qatar, data from 2013 revealed that only 
71% of smokers in the country had been advised in the 
previous 12 months to quit smoking.16
Training and Capacity-Building 
The training and capacity-building of service providers 
is a key measure in developing an infrastructure that 
supports smoking cessation and TDT, as highlighted 
by the guidelines for the implementation of Article 
14 of the FCTC.8 At a minimum, the guidelines 
recommend that HCPs be trained to record tobacco 
use among patients, provide brief advice, encourage 
attempts to quit and refer smokers to specialised TDT 
services. Additionally, the FCTC states that cessation 
training be incorporated into the curricula of all health 
professions as well as within continuous professional 
development programmes.8 Muramoto et al. noted 
that training and education in general enhances 
physicians’ confidence and their readiness to offer 
TDT services as well as advise and counsel patients on 
smoking cessation.18
In spite of the clear need for such programmes, 
there continues to be a lack of education and 
training programmes concerning TDT in healthcare 
disciplines. This was demonstrated during a survey of 
171 countries in 2009 which found that only 27% of 
medical schools taught a specific module on tobacco.19 
Specifically in the EMR countries, results from the 
Global Health Professions Student Survey indicated 
a shortage of formal training in smoking cessation 
approaches in medical schools.20 The percentage of 
medical students who reported receiving training 
ranged from approximately 40% in Kuwait, Tunisia 
and Bahrain to approximately 9% in Morocco.20 
Similar gaps in training and education were revealed 
in other healthcare disciplines.20 In a survey of medical 
students in the USA, respondents who reported 
receiving instruction, modelling and feedback on 
TDT by their preceptors in medical school had a 
higher self-reported skill level compared to those 
who recalled receiving less comprehensive training.21 
However, a lack of staff, incentive and financial 
resources to support TDT teaching appears to present 
major barriers to its implementation, preventing less 
developed countries from incorporating a tobacco 
module into their medical curricula.19 To that end, 
developing the capacity of faculty members becomes 
critical in attempts to institutionalise TDT education 
and training for students in health professions.18
A systematic review of educational- and practice-
based programmes concluded that HCPs could 
be better engaged in TDT if they were intercepted 
both during their education and once they became 
healthcare professionals; while the first affects quit 
rates among their patients, the latter is effective in 
increasing screening rates.22 A recent Cochrane 
review looked at randomised trials with interventions 
involving the training of HCPs in smoking cessation 
techniques.23 The review concluded that such training 
had a measurable effect on the continuous tobacco 
abstinence among patients and the point prevalence of 
smoking. Additionally, trained HCPs were more likely 
to make follow-up appointments, provide smoking 
cessation counselling and ask patients to set a quit 
date.23 Yet, and despite the proven value of such training 
progammes, an international survey of TDT training 
programmes could identify only four programmes in 
the EMR, training a total of 98 individuals in 2007.24
Model for Tobacco 
Dependence Treatment: King 
Hussein Cancer Center
The King Hussein Cancer Center (KHCC) is a 
comprehensive cancer care facility in Amman, Jordan. 
Since 2008, KHCC has offered TDT services to 
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TDT services. The methods employed vary between 
teaching, interactive exercises and case studies derived 
from the trainers’ own treatment practices. Pre- and 
post-workshop tests are utilised to gauge the benefits 
of the training while a workshop evaluation is used to 
collect feedback in order to inform any updates and 
upgrades to the curriculum. Workshops are conducted 
in close coordination with in-country partners who 
understand the situation within the local context and 
can influence the programme’s design and execution, 
in addition to providing continuing medical education 
accreditation for the workshops. 
The international collaboration demonstrated 
within the Global Bridges initiative is testimony to 
how a regional problem can be successfully addressed 
through global partnerships. To date, KHCC has 
trained over 1,500 HCPs and advocates from the EMR 
on tobacco control and TDT [Figure 1]. A total of 
20 workshops and conferences have been held in six 
cancer patients and the general public, endeavouring 
to address the gaps in capacity and competence that 
limit the reach of TDT services and patients’ access 
to help. Realising the importance of training HCPs 
in evidence-based treatment, KHCC started offering 
TDT training to HCPs in EMR countries in 2011. This 
was done via a collaboration with Global Bridges, an 
international healthcare TDT alliance that was co-
founded by the Mayo Clinic, the American Cancer 
Society and the University of Arizona. The Global 
Bridges initiative seeks to create opportunities to 
share treatment and advocacy expertise and to provide 
state-of-the-art training to countries around the world 
in order to help them fulfill Article 14 of the FCTC. 
While other organisations represent Global Bridges 
throughout Latin America, Africa and Europe, KHCC 
is the regional host and partner for this initiative in 
the EMR.
In this capacity, KHCC developed a standard TDT 
curriculum designed to respond to the identified needs 
and gaps in the region. The training curriculum content 
was built on internationally recognised standards and is 
implemented during a three-day workshop which aims 
to enhance the participants’ understanding of TDT as 
an integral component of tobacco control and to equip 
trainees to practice TDT and handle various cases. 
The topics covered include a general introduction 
to tobacco and its products; tobacco and NCDs; 
the process of addiction, withdrawal and relapse; 
conducting counselling and motivational interviews; 
pharmacotherapies, and building individualised 
treatment plans. Additional training sessions seek 
to present TDT in the context of tobacco control in 
general; highlight ethical issues in TDT; present the 
water-pipe as a regional and global health hazard, and 
guide participants through establishing and sustaining 
Figure 1: Graph indicating the recent cumulative growth in the number of trained healthcare providers and advocates 
attending tobacco dependence treatment training conducted by the King Hussein Cancer Centre in the Eastern 
Mediterranean region.
Figure 2: Distribution map representing the geographic 
reach of the tobacco dependence treatment training 
conducted by the King Hussein Cancer Centre in the 
Eastern Mediterranean region (EMR). Jordan, Tunisia 
and the United Arab Emirates have hosted three or 
more workshops to date. Most countries in the EMR 
region have been represented at these workshops.
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countries in the EMR; participants attended from a 
total of 19 countries, spanning Morocco to the UAE, as 
well as Iran and Afghanistan [Figure 2]. Additionally, 
the participants had varying professional backgrounds, 
including cardiology, oncology, pulmonology, general 
medical practice, nursing and pharmacology, among 
others. This diversity highlights the level of interest 
in such training and the enthusiasm for establishing 
these programmes across the region.
Other Challenges Facing 
Tobacco Dependence 
Treatment in the Eastern 
Mediterranean Region
While training programmes such as the one described 
above seek to bring about significant progress, the 
EMR continues to face other challenges that hinder 
service expansion. Political commitment across the 
region to tobacco control is not uniform and the 
tobacco industry has been gaining traction in some 
EMR countries.25–27 As developed nations around 
the world  tighten their regulations on the tobacco 
industry, the developing nations of the EMR, with 
their relaxed tobacco control regulations, may present 
a safe haven for this industry.25–27 Tobacco companies 
are state-owned in eight EMR countries, while 
multinational corporations have recently established 
operations in other Middle Eastern countries, such as 
in Jordan and Egypt.26‒28
Another challenge that may hinder the expansion of 
TDT services in the region is the prevalence of tobacco 
use among physicians and other healthcare workers. 
In 2010, 24–42% of medical students in the EMR 
were either current smokers or had previously been 
smokers.20 This undermines the role that HCPs should 
play in diminishing the social acceptability of tobacco 
use; it also reduces their credibility in promoting 
TDT services.8 It is therefore imperative that teaching 
and training programmes for HCPs address tobacco 
control and TDT early on and that special attention is 
given to first helping these professionals quit tobacco 
use themselves. 
In general, the infrastructure necessary to enable 
TDT services is not yet available in many EMR 
countries, particularly as there are no national policies 
to promote tobacco cessation. Screening for and 
recording tobacco use is not yet common practice 
among HCPs and the availability of TDT medication 
may be interrupted. Inadequate accessibility to 
services and treatment coverage present more 
barriers. In particular, the lack of treatment coverage 
is a key obstacle that needs to be addressed in parallel 
to any attempts to increase TDT services. Experiences 
in other countries have shown that the extent of 
treatment coverage influences the utilisation rate of 
cessation services; the rate of usage has the potential 
to quadruple if full coverage is provided.29‒31 Finally, 
population-level strategies that promote cessation and 
encourage smokers to quit, such as price measures 
and pictorial warnings on tobacco products, are 
either not in place or are only in the early stages of 
implementation, adding to the challenges facing the 
expansion of TDT services in this region.32 
Conclusion
In summary, the rise in the prevalence of tobacco 
use in the region is alarming and calls for quick and 
decisive action in EMR countries, specifically the 
implementation of WHO-recommended strategies 
for tobacco control. In the short term, helping smokers 
to quit is highly feasible. Enabling and training HCPs, 
potentially through international collaborations, 
should help build the skills needed to deliver effective 
TDT measures to smokers throughout the EMR.
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